Remove 2024 Remove Embolism Remove Pulmonary
article thumbnail

Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

DAIC

The risk factors for postoperative embolism included Black race, interstitial fibrosis, advanced-stage disease requiring bilobectomy or pneumonectomy, and increased operative duration. occurrence of postoperative PE in patients undergoing a first-time pulmonary resection for lung cancer. occurrence of postoperative VTE and a 1.3%

Cancer 116
article thumbnail

VA-ECOM assisted percutaneous mechanical thrombectomy treatment high-risk pulmonary embolism

Frontiers in Cardiovascular Medicine

BackgroundPercutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. The mortality rate was 27.3%

article thumbnail

FDA Approves Jupiter Endo Pivotal Trial for Pulmonary Embolism

DAIC

tim.hodson Wed, 09/04/2024 - 15:34 Aug. 29, 2024 – Jupiter Endovascular, Inc., SPIRARE II is a prospective, single-arm, multicenter pivotal trial that will enroll up to 145 patients with acute, intermediate-risk PE treated with the Vertex Pulmonary Embolectomy System at up to 25 U.S. recently announced that the U.S.

article thumbnail

Avicenna.AI Secures FDA Clearance for Two Healthcare AI Solutions

DAIC

milla1cf Tue, 03/26/2024 - 11:12 March 26, 2024 — Medical imaging AI company Avicenna.AI announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products. CINA-iPE and CINA-ASPECTS are the latest tools from Avicenna.AI

Embolism 105
article thumbnail

Emerging technology : An Intelligent vacuum thrombo-aspiration system for Acute pulmonary embolism

Dr. S. Venkatesan MD

A new Intelligent thrombo-suction catheter system , is being introduced for treatment of acute pulmonary embolism.This device regulates the force with which thrombus is sucked , with less injury and bleeding and better outcomes. Human studies & Evidence The experience from this device was presented in ESC 2024 London.

article thumbnail

Novel thrombectomy system demonstrates positive safety and feasibility results in treating acute pulmonary embolism

Medical Xpress - Cardiology

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE).

article thumbnail

Impact of Time to Catheter-Based Therapy on Outcomes in Acute Pulmonary Embolism

Circulation: Cardiovascular Interventions

BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This Patients were divided into early (<12 hours) and delayed CBT (12 hours) groups.